DENTSPLY SIRONA Inc. (XRAY)
USD 18.68
(-2.66%)
USD 18.68
(-2.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -85 Million USD | -3.59% |
| 2022 | 306 Million USD | -50.8% |
| 2021 | 622 Million USD | 36.4% |
| 2020 | 456 Million USD | -12.69% |
| 2019 | 522.3 Million USD | 154.51% |
| 2018 | -958.1 Million USD | 39.56% |
| 2017 | -1.58 Billion USD | -448.65% |
| 2016 | 454.7 Million USD | 21.19% |
| 2015 | 375.2 Million USD | -15.8% |
| 2014 | 445.6 Million USD | 6.31% |
| 2013 | 419.16 Million USD | 9.75% |
| 2012 | 381.93 Million USD | 27.0% |
| 2011 | 300.72 Million USD | -20.92% |
| 2010 | 380.27 Million USD | -0.24% |
| 2009 | 381.18 Million USD | 0.2% |
| 2008 | 380.42 Million USD | 7.19% |
| 2007 | 354.89 Million USD | 12.74% |
| 2006 | 314.79 Million USD | 331.69% |
| 2005 | 72.92 Million USD | -75.29% |
| 2004 | 295.13 Million USD | 10.13% |
| 2003 | 267.98 Million USD | 4.48% |
| 2002 | 256.5 Million USD | 43.81% |
| 2001 | 178.36 Million USD | 8.85% |
| 2000 | 163.86 Million USD | 9.53% |
| 1999 | 149.6 Million USD | 5.87% |
| 1998 | 141.3 Million USD | 6.64% |
| 1997 | 132.5 Million USD | 10.88% |
| 1996 | 119.5 Million USD | 18.67% |
| 1995 | 100.7 Million USD | 3.28% |
| 1994 | 97.5 Million USD | 23.73% |
| 1993 | 78.8 Million USD | 525.4% |
| 1992 | 12.6 Million USD | 59.49% |
| 1991 | 7.9 Million USD | 68.09% |
| 1990 | 4.7 Million USD | 74.07% |
| 1989 | 2.7 Million USD | 12.5% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 73 Million USD | 73.81% |
| 2024 Q1 | 42 Million USD | -42.47% |
| 2023 Q4 | 73 Million USD | 130.93% |
| 2023 Q1 | 54 Million USD | 220.0% |
| 2023 FY | 295 Million USD | -3.59% |
| 2023 Q3 | -236 Million USD | -395.0% |
| 2023 Q2 | 80 Million USD | 48.15% |
| 2022 Q4 | -45 Million USD | -175.0% |
| 2022 Q3 | 60 Million USD | -49.58% |
| 2022 Q2 | 119 Million USD | 27.96% |
| 2022 Q1 | 93 Million USD | -39.61% |
| 2022 FY | 306 Million USD | -50.8% |
| 2021 Q2 | 155 Million USD | 0.65% |
| 2021 FY | 622 Million USD | 36.4% |
| 2021 Q4 | 154 Million USD | -3.14% |
| 2021 Q1 | 154 Million USD | 14.07% |
| 2021 Q3 | 159 Million USD | 2.58% |
| 2020 Q3 | 81.7 Million USD | 178.33% |
| 2020 FY | 456 Million USD | -12.69% |
| 2020 Q1 | -124.8 Million USD | -191.36% |
| 2020 Q4 | 135 Million USD | 65.24% |
| 2020 Q2 | -104.3 Million USD | 16.43% |
| 2019 FY | 522.3 Million USD | 154.51% |
| 2019 Q2 | 67.5 Million USD | 42.71% |
| 2019 Q4 | 136.6 Million USD | 24.75% |
| 2019 Q3 | 109.5 Million USD | 62.22% |
| 2019 Q1 | 47.3 Million USD | -42.18% |
| 2018 Q1 | 68.7 Million USD | 109.42% |
| 2018 Q4 | 81.8 Million USD | 79.78% |
| 2018 Q3 | 45.5 Million USD | 103.94% |
| 2018 FY | -958.1 Million USD | 39.56% |
| 2018 Q2 | -1.15 Billion USD | -1779.91% |
| 2017 Q4 | -729.4 Million USD | -776.0% |
| 2017 FY | -1.58 Billion USD | -448.65% |
| 2017 Q3 | 107.9 Million USD | 110.3% |
| 2017 Q2 | -1.04 Billion USD | -1344.66% |
| 2017 Q1 | 84.2 Million USD | -37.26% |
| 2016 FY | 454.7 Million USD | 21.19% |
| 2016 Q1 | 72.7 Million USD | -21.91% |
| 2016 Q4 | 134.2 Million USD | 6.0% |
| 2016 Q3 | 126.6 Million USD | 4.46% |
| 2016 Q2 | 121.2 Million USD | 66.71% |
| 2015 FY | 375.2 Million USD | -15.8% |
| 2015 Q3 | 98.6 Million USD | 14.92% |
| 2015 Q4 | 93.1 Million USD | -5.58% |
| 2015 Q2 | 85.8 Million USD | -12.19% |
| 2015 Q1 | 97.7 Million USD | -5.45% |
| 2014 Q3 | 109.58 Million USD | -13.79% |
| 2014 Q1 | 105.57 Million USD | 8.36% |
| 2014 FY | 445.6 Million USD | 6.31% |
| 2014 Q4 | 103.34 Million USD | -5.69% |
| 2014 Q2 | 127.1 Million USD | 20.4% |
| 2013 Q1 | 93.85 Million USD | -3.45% |
| 2013 Q2 | 122.86 Million USD | 30.91% |
| 2013 Q3 | 105.02 Million USD | -14.52% |
| 2013 Q4 | 97.42 Million USD | -7.24% |
| 2013 FY | 419.16 Million USD | 9.75% |
| 2012 Q1 | 87.16 Million USD | 33.4% |
| 2012 Q2 | 108.9 Million USD | 24.95% |
| 2012 Q3 | 88.66 Million USD | -18.59% |
| 2012 Q4 | 97.2 Million USD | 9.63% |
| 2012 FY | 381.93 Million USD | 27.0% |
| 2011 Q1 | 98.58 Million USD | 3.16% |
| 2011 FY | 300.72 Million USD | -20.92% |
| 2011 Q4 | 65.33 Million USD | 64.16% |
| 2011 Q3 | 39.8 Million USD | -58.97% |
| 2011 Q2 | 97 Million USD | -1.6% |
| 2010 Q2 | 104.96 Million USD | 17.51% |
| 2010 Q3 | 90.41 Million USD | -13.86% |
| 2010 Q4 | 95.56 Million USD | 5.69% |
| 2010 FY | 380.27 Million USD | -0.24% |
| 2010 Q1 | 89.32 Million USD | -13.59% |
| 2009 Q4 | 103.37 Million USD | 11.24% |
| 2009 FY | 381.18 Million USD | 0.2% |
| 2009 Q3 | 92.93 Million USD | -5.85% |
| 2009 Q1 | 86.17 Million USD | 1.01% |
| 2009 Q2 | 98.7 Million USD | 14.55% |
| 2008 Q4 | 85.31 Million USD | 5.43% |
| 2008 Q2 | 113.16 Million USD | 12.0% |
| 2008 Q1 | 101.03 Million USD | 3.52% |
| 2008 FY | 380.42 Million USD | 7.19% |
| 2008 Q3 | 80.91 Million USD | -28.5% |
| 2007 Q4 | 97.59 Million USD | 18.17% |
| 2007 Q1 | 81.21 Million USD | 1.95% |
| 2007 FY | 354.89 Million USD | 12.74% |
| 2007 Q2 | 93.49 Million USD | 15.12% |
| 2007 Q3 | 82.59 Million USD | -11.66% |
| 2006 FY | 314.79 Million USD | 331.69% |
| 2006 Q4 | 79.65 Million USD | 1.42% |
| 2006 Q3 | 78.53 Million USD | -9.3% |
| 2006 Q2 | 86.59 Million USD | 23.69% |
| 2006 Q1 | 70 Million USD | 422.54% |
| 2005 Q2 | 81.13 Million USD | 15.7% |
| 2005 Q3 | -56.63 Million USD | -169.8% |
| 2005 Q4 | -21.7 Million USD | 61.67% |
| 2005 Q1 | 70.12 Million USD | -11.62% |
| 2005 FY | 72.92 Million USD | -75.29% |
| 2004 Q1 | 70.1 Million USD | 0.73% |
| 2004 Q4 | 79.34 Million USD | 16.5% |
| 2004 Q3 | 68.11 Million USD | -12.19% |
| 2004 Q2 | 77.56 Million USD | 10.64% |
| 2004 FY | 295.13 Million USD | 10.13% |
| 2003 Q1 | 62.01 Million USD | -13.4% |
| 2003 Q4 | 69.6 Million USD | 6.51% |
| 2003 Q3 | 65.34 Million USD | -7.99% |
| 2003 Q2 | 71.02 Million USD | 14.54% |
| 2003 FY | 267.98 Million USD | 4.48% |
| 2002 FY | 256.5 Million USD | 43.81% |
| 2002 Q3 | 61.83 Million USD | -5.57% |
| 2002 Q4 | 71.6 Million USD | 15.81% |
| 2002 Q1 | 57.58 Million USD | 5.29% |
| 2002 Q2 | 65.47 Million USD | 13.7% |
| 2001 Q3 | 44.41 Million USD | 0.17% |
| 2001 Q4 | 54.69 Million USD | 23.16% |
| 2001 Q1 | 28.51 Million USD | -42.11% |
| 2001 Q2 | 44.33 Million USD | 55.5% |
| 2001 FY | 178.36 Million USD | 8.85% |
| 2000 Q4 | 49.25 Million USD | 29.14% |
| 2000 Q3 | 38.13 Million USD | -4.01% |
| 2000 Q2 | 39.73 Million USD | 8.14% |
| 2000 Q1 | 36.74 Million USD | -16.88% |
| 2000 FY | 163.86 Million USD | 9.53% |
| 1999 Q3 | 34.7 Million USD | -4.67% |
| 1999 FY | 149.6 Million USD | 5.87% |
| 1999 Q1 | 34.3 Million USD | -19.29% |
| 1999 Q2 | 36.4 Million USD | 6.12% |
| 1999 Q4 | 44.2 Million USD | 27.38% |
| 1998 Q3 | 31.9 Million USD | -9.63% |
| 1998 Q4 | 42.5 Million USD | 33.23% |
| 1998 FY | 141.3 Million USD | 6.64% |
| 1998 Q1 | 31.5 Million USD | -25.18% |
| 1998 Q2 | 35.3 Million USD | 12.06% |
| 1997 Q2 | 32.5 Million USD | 15.66% |
| 1997 FY | 132.5 Million USD | 10.88% |
| 1997 Q4 | 42.1 Million USD | 40.8% |
| 1997 Q3 | 29.9 Million USD | -8.0% |
| 1997 Q1 | 28.1 Million USD | -23.22% |
| 1996 Q2 | 31.2 Million USD | 15.99% |
| 1996 FY | 119.5 Million USD | 18.67% |
| 1996 Q4 | 36.6 Million USD | 48.78% |
| 1996 Q3 | 24.6 Million USD | -21.15% |
| 1996 Q1 | 26.9 Million USD | -19.94% |
| 1995 FY | 100.7 Million USD | 3.28% |
| 1995 Q4 | 33.6 Million USD | 94.22% |
| 1995 Q3 | 17.3 Million USD | -35.69% |
| 1995 Q2 | 26.9 Million USD | 17.47% |
| 1995 Q1 | 22.9 Million USD | -13.58% |
| 1994 FY | 97.5 Million USD | 23.73% |
| 1994 Q1 | 23.2 Million USD | -9.38% |
| 1994 Q2 | 25.5 Million USD | 9.91% |
| 1994 Q3 | 24.6 Million USD | -3.53% |
| 1994 Q4 | 26.5 Million USD | 7.72% |
| 1993 FY | 78.8 Million USD | 525.4% |
| 1993 Q4 | 25.6 Million USD | 2.81% |
| 1993 Q3 | 24.9 Million USD | 378.85% |
| 1993 Q2 | 5.2 Million USD | -39.53% |
| 1993 Q1 | 8.6 Million USD | 11.69% |
| 1992 Q2 | 4.3 Million USD | 10.26% |
| 1992 FY | 12.6 Million USD | 59.49% |
| 1992 Q3 | 6.8 Million USD | 58.14% |
| 1992 Q4 | 7.7 Million USD | 13.24% |
| 1992 Q1 | 3.9 Million USD | 18.18% |
| 1991 Q2 | 2.5 Million USD | -7.41% |
| 1991 Q3 | 3 Million USD | 20.0% |
| 1991 FY | 7.9 Million USD | 68.09% |
| 1991 Q1 | 2.7 Million USD | 0.0% |
| 1991 Q4 | 3.3 Million USD | 10.0% |
| 1990 Q4 | 2.7 Million USD | 80.0% |
| 1990 FY | 4.7 Million USD | 74.07% |
| 1990 Q3 | 1.5 Million USD | 25.0% |
| 1990 Q2 | 1.2 Million USD | 9.09% |
| 1990 Q1 | 1.1 Million USD | -15.38% |
| 1989 Q4 | 1.3 Million USD | 8.33% |
| 1989 Q1 | -11.3 Million USD | -330.61% |
| 1989 Q3 | 1.2 Million USD | 0.0% |
| 1989 Q2 | 1.2 Million USD | 110.62% |
| 1989 FY | 2.7 Million USD | 12.5% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -57.66 Million USD | -47.395% |
| AngioDynamics, Inc. | -97.71 Million USD | 13.015% |
| AtriCure, Inc. | -26.68 Million USD | -218.555% |
| Avinger, Inc. | -16.63 Million USD | -410.971% |
| Azenta, Inc. | -73.12 Million USD | -16.238% |
| BioLife Solutions, Inc. | -70.82 Million USD | -20.014% |
| The Cooper Companies, Inc. | 533.1 Million USD | 115.944% |
| Daxor Corporation | -177.07 Thousand USD | -47902.259% |
| Ekso Bionics Holdings, Inc. | -15.11 Million USD | -462.467% |
| Femasys Inc. | -14.5 Million USD | -485.867% |
| GlucoTrack, Inc. | -7.1 Million USD | -1096.509% |
| Harvard Bioscience, Inc. | 1.89 Million USD | 4587.856% |
| Hologic, Inc. | 882.6 Million USD | 109.631% |
| ICU Medical, Inc. | 22.82 Million USD | 472.399% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 104.811% |
| KORU Medical Systems, Inc. | -10.26 Million USD | -727.655% |
| LeMaitre Vascular, Inc. | 37.08 Million USD | 329.222% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -1131.787% |
| Innovative Eyewear, Inc. | -6.9 Million USD | -1131.787% |
| Masimo Corporation | 136.5 Million USD | 162.271% |
| Microbot Medical Inc. | -9.85 Million USD | -762.506% |
| Meihua International Medical Technologies Co., Ltd. | 14.67 Million USD | 679.219% |
| Merit Medical Systems, Inc. | 123.94 Million USD | 168.579% |
| Nephros, Inc. | -1.59 Million USD | -5235.844% |
| NovoCure Limited | -232.87 Million USD | 63.499% |
| NEXGEL, Inc. | -3.47 Million USD | -2344.636% |
| NEXGEL, Inc. | -3.47 Million USD | -2344.636% |
| Singular Genomics Systems, Inc. | -102.8 Million USD | 17.316% |
| OraSure Technologies, Inc. | 54.07 Million USD | 257.177% |
| Pro-Dex, Inc. | 7.17 Million USD | 1284.999% |
| Pulse Biosciences, Inc. | -43.57 Million USD | -95.07% |
| Predictive Oncology Inc. | -13.92 Million USD | -510.574% |
| Precision Optics Corporation, Inc. | -2.72 Million USD | -3020.03% |
| QuidelOrtho Corporation | 139.1 Million USD | 161.107% |
| Repligen Corporation | 54.57 Million USD | 255.746% |
| Sanara MedTech Inc. | -4.21 Million USD | -1916.534% |
| STAAR Surgical Company | 28.09 Million USD | 402.523% |
| Sharps Technology, Inc. | -10.12 Million USD | -739.369% |
| Utah Medical Products, Inc. | 16.77 Million USD | 606.646% |
| Jin Medical International Ltd. | 2.86 Million USD | 3064.501% |